Results 31 to 40 of about 2,383,672 (201)

Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk

open access: yesHaematologica, 2017
The importance of the tumor microenvironment in chronic lymphocytic leukemia is widely accepted. Nevertheless, the understanding of the complex interplay between the various types of bystander cells and chronic lymphocytic leukemia cells is incomplete ...
Martijn HA van Attekum   +2 more
doaj   +1 more source

The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.

open access: yesPLoS ONE, 2021
Flow cytometry immunophenotyping has an essential role in distinguishing chronic lymphocytic leukemia from other B-chronic lymphoproliferative disorders. Recently, CD200 is considered as a relatively consistent marker in chronic lymphocytic leukemia.
Sana Dlawar Jalal
doaj   +1 more source

Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin’s lymphomas among relatives of patients with chronic lymphocytic leukemia

open access: yesHaematologica, 2009
Background Previous studies have shown increased familial risk for chronic lymphocytic leukemia. In the most comprehensive study to date, we evaluated risk of chronic lymphocytic leukemia and lymphoproliferative disorders among first-degree relatives of ...
Lynn R. Goldin   +4 more
doaj   +1 more source

Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia [PDF]

open access: yes, 2006
The aim of this multicenter GIMEMA study was to correlate autoimmune complications (AIC) in B-cell chronic lymphocytic leukemia (B-CLL) with stage and therapy.
A. Ambrosetti   +19 more
core   +1 more source

Prognostic factors for survival in patiens with chronic lymphocytic leukemia [PDF]

open access: yes, 2012
The purpose of this study is to analyse the quality of the prognostic factors to prognose the survival time and progression for patients with chronic lymphocytic leukemia (CLL) in early stage.
Wijaya, Ferry
core   +1 more source

Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study

open access: yesFrontiers in Hematology
BackgroundDisease-specific factors associated with decreased quality of life (QoL) in patients with leukemia have not been studied in a large-scale, global, observational study.MethodsThis cross-sectional study used the validated Hematological Malignancy
Sam Salek   +12 more
doaj   +1 more source

Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia

open access: yesHaematologica, 2018
Chronic lymphocytic leukemia is a disease with up-regulated expression of the transmembrane tyrosine-protein kinase ROR1, a member of the Wnt/planar cell polarity pathway. In this study, we identified COBLL1 as a novel interaction partner of ROR1. COBLL1
Hana Plešingerová   +12 more
doaj   +1 more source

Chronic lymphocytic leukemia relapse presenting as acute otitis media with facial palsy

open access: yesEgyptian Journal of Ear, Nose, Throat and Allied Sciences, 2015
Objective: To describe a case of chronic lymphocytic leukemia relapses presenting as bilateral acute otitis media with left facial paralysis. Methods: Case report and review of the literature. Introduction: Chronic lymphocytic leukemia is the most common
Mai Nasser   +2 more
doaj   +1 more source

Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study

open access: yes, 2023
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus ...
Chiara Adele Cavarretta   +89 more
core   +1 more source

Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL

open access: yesBlood Advances
: Chronic lymphocytic leukemia (CLL) presents challenges in treatment despite advancements in targeted therapies, often facing resistance or relapse. Chronic inflammation plays a significant role in CLL biology, with heightened inflammatory responses and
Angimar Uriepero-Palma   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy